Abstract
The LDL receptor-associated protein (RAP) is involved in secretion of thyroglobulin (Tg) from the thyrocyte to the colloid. Disruption of the RAP gene in mice results in a reduced Tg content within the colloid, leading to subclinical hypothyroidism and histological alterations resembling early goiter. Here we studied the entire coding sequence of RAP in genomic DNA samples from 18 patients with primary hypothyroidism not due to thyroid autoimmunity or dysgenesis. the control group included 21 subjects with no evidence of thyroid alterations. Eleven different polymorphisms with amino-acid substitution and 4 different missense polymorphisms without amino-acid substitution were found in various regions of the RAP gene. Only one polymorphism in exone 7 (V311M) was observed exclusively in patients, but it had been previously reported in normal subjects as well. The remaining polymorphisms were found either both in patients and controls or only in controls and had not been previously reported. The frequency of the various polymorphisms did not differ significantly between patients and controls. based on these findings, we conclude that alterations of the RAP gene are not a common cause of hypothyroidism, although it cannot be excluded that other, rarer alterations with a pathogenic effect exist, and that they should be investigated in a larger number of patients.
Similar content being viewed by others
References
Bu G. The roles of receptor-associated protein (RAP) as a molecular chaperone for members of the LDL receptor family. Int Rev Cytol 2001, 209: 79–116.
Willnow TE. Receptor-associated protein (RAP): a specialized chaperone for endocytic receptors. Biol Chem 1998, 379: 1025–31.
Botta R, Lisi S, Pinchera A, et al. TSH-dependent expression of the LDL receptor-associated protein (RAP) in thyroid epithelial cells. Thyroid 2006, 16: 1097–104.
Marinò M, Zheng G, Chiovato L, et al. Role of megalin (gp330) in transcytosis of thyroglobulin by thyroid cells. A novel function in the control of thyroid hormone release. J Biol Chem 2000, 275: 7125–37.
Lisi S, Pinchera A, McCluskey RT, et al. Preferential megalin-mediated transcytosis of low-hormonogenic thyroglobulin: a control mechanism for thyroid hormone release. Proc Natl Acad Sci USA 2003, 100: 14858–63.
Lisi S, Botta R, Pinchera A, et al. Defective thyroglobulin storage in LDL receptor associated protein deficient mice. Am J Physiol Cell Physiol 2006, 290: C1160–7.
Marinò M, Chiovato L, Lisi S, Pinchera A, McCluskey RT. Binding of the low density lipoprotein receptor-associated protein (RAP) to thyroglobulin (Tg): putative role of RAP in the Tg secretory pathway. Mol Endocrinol 2001, 15: 1829–37.
Lisi S, Chiovato L, Pinchera A, et al. Impaired thyroglobulin (Tg) secretion by FRTL-5 cells transfected with soluble receptor associated protein (RAP): evidence for a role of RAP in the Tg biosynthetic pathway. J Endocrinol Invest 2003, 26: 1105–10.
Zheng G, Marinò M, Zhao J, McCluskey RT. Megalin (gp330): a putative endocytic receptor for thyroglobulin (Tg). Endocrinology 1998, 139: 1462–5.
Van Leuven F, Thiry E, Stas L, Nelissen B. Analysis of the human LRPAP1 gene coding for the lipoprotein receptor-associated protein: identification of 22 polymorphisms and one mutation. Genomics 1998, 52: 145–51.
Van Leuven F, Hilliker C, Serneels L, et al. Cloning, characterization, and chromosomal localization to 4p16 of the human gene (LRPAP1) coding for the alpha 2-macroglobulin receptor-associated protein and structural comparison with the murine gene coding forthe 44-kDa heparin-binding protein. Genomics 1995, 20: 492–500.
Bu G, Rennke S. Receptor-associated protein is a folding chaperone for low density lipoprotein receptor-related protein. J Biol Chem 1996, 271: 22218–24.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lisi, S., Botta, R., Pinchera, A. et al. Sequencing of the entire coding region of the receptor associated protein (RAP) in patients with primary hypothyroidism of unknown origin. J Endocrinol Invest 30, 839–843 (2007). https://doi.org/10.1007/BF03349225
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349225